Literature DB >> 33261846

In vitro adjuvant antitumor activity of various classes of semi-synthetic poststerone derivatives.

Rimma G Savchenko1, Márta Nové2, Gabriella Spengler2, Attila Hunyadi3, Lyudmila V Parfenova4.   

Abstract

Various classes of semi-synthetic analogs of poststerone, the product of oxidative cleavage of the C20-C22 bond in the side chain of the phytoecdysteroid 20-hydroxyecdysone, were synthesized. The analogs were obtained by reductive transformations using L-Selectride and H2-Pd/C, by molecular abeo-rearrangements using the DAST reagent or ultrasonic treatment in the NaI-Zn-DMF system, and by acid-catalyzed reactions of poststerone derivatives with various aldehydes (o-FC6H4CHO, m-CF3C6H4CHO, CO2Me(CH2)8CHO). The products were tested on a mouse lymphoma cell line pair, L5178 and its ABCB1-transfected multi-drug resistant counterpart, L5178MDR, for their in vitro activity alone and in combination with doxorubicin, and for the ability to inhibit the ABCB1 transporter. Among the tested compounds, new 2,3-dioxolane derivatives of the pregnane ecdysteroid were found to have a pronounced chemosensitizing activity towards doxorubicin and could be considered as promising candidates for further structure optimization for the development of effective chemosensitizing agents.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjuvant; Chemo-sensitization; Dioxolanes; Ecdysteroids; Multidrug resistance

Year:  2020        PMID: 33261846     DOI: 10.1016/j.bioorg.2020.104485

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  1 in total

1.  Diversity-Oriented Synthesis Catalyzed by Diethylaminosulfur-Trifluoride-Preparation of New Antitumor Ecdysteroid Derivatives.

Authors:  Máté Vágvölgyi; Endre Kocsis; Márta Nové; Nikoletta Szemerédi; Gabriella Spengler; Zoltán Kele; Róbert Berkecz; Tamás Gáti; Gábor Tóth; Attila Hunyadi
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.